# Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients

> **NCT01758939** · — · UNKNOWN · sponsor: **Cairo University** · enrollment: 100000 (estimated)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01758939
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2016-01
- **Final completion:** 2017-01
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2013-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758939, "Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT01758939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*